Lexaria Bioscience Corp. (LEXX)
NASDAQ: LEXX · Real-Time Price · USD
0.730
-0.099 (-11.98%)
At close: Mar 9, 2026, 4:00 PM EDT
0.722
-0.008 (-1.06%)
After-hours: Mar 9, 2026, 7:28 PM EDT

Lexaria Bioscience Ratios and Metrics

Millions USD. Fiscal year is Sep - Aug.
Fiscal Year
CurrentFY 2025 FY 2024 FY 2023 FY 2022 FY 2021 2020 - 2016
Period Ending
Mar '26 Aug '25 Aug '24 Aug '23 Aug '22 Aug '21 2020 - 2016
Market Capitalization
18176281835
Upgrade
Market Cap Growth
-27.67%-72.15%627.66%-51.77%-50.18%13.53%
Upgrade
Enterprise Value
14125351027
Upgrade
Last Close Price
0.830.883.911.052.966.22
Upgrade
PS Ratio
34.2624.39133.1537.5668.9748.92
Upgrade
PB Ratio
3.756.628.073.172.312.71
Upgrade
P/TBV Ratio
3.886.428.223.292.362.74
Upgrade
EV/Sales Ratio
25.9817.46114.3321.5839.4437.19
Upgrade
Debt / Equity Ratio
0.020.040.020.060.010.01
Upgrade
Net Debt / Equity Ratio
-0.96-0.71-0.84-0.49-0.80-0.89
Upgrade
Net Debt / EBITDA Ratio
0.410.161.140.210.942.09
Upgrade
Net Debt / FCF Ratio
0.500.181.280.221.242.92
Upgrade
Asset Turnover
0.070.110.080.040.020.09
Upgrade
Inventory Turnover
----2.112.39
Upgrade
Quick Ratio
3.101.566.105.9932.7978.90
Upgrade
Current Ratio
3.682.327.188.0435.9681.18
Upgrade
Return on Equity (ROE)
-155.23%-232.15%-112.36%-130.18%-71.35%-73.16%
Upgrade
Return on Assets (ROA)
-82.96%-111.49%-59.56%-73.59%-39.21%-44.17%
Upgrade
Return on Capital Employed (ROCE)
-228.90%-433.80%-73.30%-228.20%-86.60%-43.40%
Upgrade
Earnings Yield
-60.35%-69.13%-9.38%-78.45%-41.27%-11.39%
Upgrade
FCF Yield
-48.69%-60.84%-8.09%-69.63%-27.98%-11.28%
Upgrade
Buyback Yield / Dilution
-34.21%-45.34%-87.24%-12.38%-34.02%-58.34%
Upgrade
Source: S&P Capital IQ. Standard template. Financial Sources.